Showing 2,061 news articles about PrEP

Filters Content type: Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Improving HIV care

ECDC releases new standards to improve HIV prevention and care

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
27 June 2025
PrEP policies & guidelines

Supreme Court endorses Obamacare panel that requires free preventive care

Editor's pick
NBC News
27 June 2025
Injectable & long-acting PrEP

Will long-lasting HIV preventive be a game changer—or a missed opportunity?

Editor's pick
Science Magazine
24 June 2025
Vaginal rings & topical PrEP

HIV Prevention Vaginal Ring Recommended for 16-Year-Olds

Editor's pick
Medscape (requires free registration)
24 June 2025
Injectable & long-acting PrEP

HIV protection with just two shots a year: FDA approves Gilead drug

Editor's pick
STAT
19 June 2025
Injectable & long-acting PrEP

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection

Editor's pick
Gilead Sciences press release
19 June 2025
Pharmaceutical industry

FDA approves twice-yearly shot of Gilead drug for HIV prevention

Editor's pick
BioPharma Dive
19 June 2025
Injectable & long-acting PrEP

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Editor's pick
The Guardian
17 June 2025
Injectable & long-acting PrEP

New Report: Getting PrEP Rollout Right This Time

Editor's pick
AVAC
12 June 2025
PrEP programmes & uptake

Major Real-World Study Affirms: PrEP Is Good—and the More PrEP, the Better

Editor's pick
TheBodyPro
9 June 2025
Injectable & long-acting PrEP

Uncertain road ahead for lenacapavir, a new ‘breakthrough’ HIV prevention drug

Editor's pick
Positively Aware
5 June 2025
Injectable & long-acting PrEP

Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty

Editor's pick
Reuters
2 June 2025
Global health initiatives

Rollout of ‘miracle’ HIV prevention drug is threatened by Trump cuts to global AIDS relief program

Editor's pick
STAT
1 April 2025
HIV prevention policy

PrEP in the Balance

Editor's pick
AVAC
28 March 2025
Adherence

Urine testing plus feedback can increase PrEP adherence in pregnant women

Editor's pick
Healio
17 March 2025
Injectable & long-acting PrEP

Annual jab for HIV protection passes trial hurdle

Editor's pick
BBC News
17 March 2025
PrEP policies & guidelines

US: Government-Mandated PrEP Coverage Mostly Survives Appeals Court Ruling; Threats Still Loom

Editor's pick
TheBody
27 June 2024
Adherence

Overcoming the Challenges of Adhering to Injectable ART and PrEP

Editor's pick
Infectious Disease Special Edition
26 June 2024
PrEP programmes & uptake

How PrEP4Teens Constructed a Rigorously Researched, Teen-Led Sexual-Health Program

Editor's pick
TheBodyPro
26 June 2024
People & personal stories

Moupali Das, M.D., M.P.H., Designed the Lenacapavir Study With Black and Brown Girls in Mind

Editor's pick
TheBody
25 June 2024
Injectable & long-acting PrEP

Statement From The Gilead’s Purpose 1 Global Community Accountability Board, The African Women’s Prevention Community Accountability Board, Our Partners And Community Partners

Editor's pick
African Women’s Prevention Community Accountability Board
24 June 2024
PrEP policies & guidelines

Appeals court finds 'Obamacare' pillar unconstitutional in suit over HIV-prevention drug

Editor's pick
NBC News
24 June 2024
Vaginal rings & topical PrEP

Vaginal Ring for PrEP Found Effective and Safe During Pregnancy

Editor's pick
Infectious Disease Special Edition
24 June 2024
Injectable & long-acting PrEP

Unitaid calls for accelerated global access to long-acting HIV prevention drug lenacapavir after positive trial results

Editor's pick
Unitaid
21 June 2024